Literature DB >> 19100681

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.

Julie A Kelly1, M Scott Lucia, James R Lambert.   

Abstract

The p53 tumor suppressor modulates cellular response to stress through both transcriptional and post-transcriptional mechanisms. Elucidation of the downstream targets of p53 following cell stress will aid in our understanding of the pathways involved in cellular adaptation to stressful stimuli. Here, we demonstrate that the TGF-beta superfamily member, and putative tumor suppressor, prostate-derived factor (PDF)/NSAID-activated gene (NAG)-1/macrophage inhibitory cytokine (MIC)-1 is induced in LNCaP human prostate cancer cells following treatment with the DNA-damaging agent, doxorubicin, culture under hypoxic conditions and by the hypoxia mimetic, cobalt chloride. Additionally, PDF expression was induced by increasing cell density. Expression of dominant negative p53 in LNCaP cells blocked induction of PDF mRNA and protein demonstrating the requirement for functional p53 in PDF induction by these stimuli. DNA damage and hypoxia resulted in increased p53 protein accumulation indicating that PDF expression may be controlled by cellular levels of p53. We also show the requirement for de novo protein synthesis in PDF induction by hypoxia and DNA damage. Increased PDF mRNA stability in response to hypoxia and cobalt chloride, but not doxorubicin, indicates that p53-dependent induction of PDF expression occurs via diverse mechanisms. Thus, PDF may represent a novel target of p53 in response to cell stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100681     DOI: 10.1016/j.canlet.2008.11.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

Review 2.  Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.

Authors:  Seung Joon Baek; Thomas Eling
Journal:  Pharmacol Ther       Date:  2019-02-18       Impact factor: 12.310

3.  Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death.

Authors:  M F Jones; X Ling Li; M Subramanian; Svetlana A Shabalina; T Hara; Y Zhu; J Huang; Y Yang; L M Wakefield; K V Prasanth; A Lal
Journal:  Cell Death Differ       Date:  2015-02-20       Impact factor: 15.828

Review 4.  COX inhibitors directly alter gene expression: role in cancer prevention?

Authors:  Xingya Wang; Seung Joon Baek; Thomas Eling
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 5.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.

Authors:  Jawed Akhtar Siddiqui; Ramesh Pothuraju; Parvez Khan; Gunjan Sharma; Sakthivel Muniyan; Parthasarathy Seshacharyulu; Maneesh Jain; Mohd Wasim Nasser; Surinder Kumar Batra
Journal:  Cytokine Growth Factor Rev       Date:  2021-11-17       Impact factor: 7.638

Review 6.  Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.

Authors:  Sakthivel Muniyan; Ramesh Pothuraju; Parthasarathy Seshacharyulu; Surinder K Batra
Journal:  Cancer Lett       Date:  2022-03-26       Impact factor: 9.756

Review 7.  Moonlighting proteins in cancer.

Authors:  Kyung-Won Min; Seong-Ho Lee; Seung Joon Baek
Journal:  Cancer Lett       Date:  2015-10-20       Impact factor: 8.679

8.  Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus.

Authors:  Jun Li; Lijun Yang; Weijun Qin; Geng Zhang; Jianlin Yuan; Fuli Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 9.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.

Authors:  Ramu Adela; Sanjay K Banerjee
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

10.  Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.

Authors:  Yasmin Husaini; Min Ru Qiu; Glen P Lockwood; Xu Wei Luo; Ping Shang; Tamara Kuffner; Vicky Wang-Wei Tsai; Lele Jiang; Pamela J Russell; David A Brown; Samuel N Breit
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.